跳到内容

肿瘤科(儿科)

止血的管理和优化

抗纤溶药物

Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. (打开新窗口)

Antun AG, Gleason S, Arellano M, Langston AA, McLemore ML, Gaddh M, el Rassi F, Bernal-Mizrachi L, Galipeau J, Heffner LT Jr, Winton EF, Khoury HJ.

来源‎: Cancer 2013;119(21):3784-7.

检索‎: PubMed 23921838

DOI码‎: 10.1002/cncr.28253

https://www.ncbi.nlm.nih.gov/pubmed/23921838 (打开新窗口)

Low dose bolus aminocaproic acid: an alternative to platelet transfusion in thrombocytopenia? (打开新窗口)

Chakrabarti S, Varma S, Singh S, Kumari S

来源‎: Eur J Haematol 1998;60(5):313-4.

检索‎: PubMed 9654162

DOI码‎: 10.1111/j.1600-0609.1998.tb01046.x

https://www.ncbi.nlm.nih.gov/pubmed/9654162 (打开新窗口)

The use of antifibrinolytics in pediatric patients with hypoproliferative thrombocytopenia. (打开新窗口)

Delaney M, Matthews DC, Gernsheimer TB

来源‎: Pediatr Blood Cancer 2017;64(12):e26641.

检索‎: PubMed 28544698

DOI码‎: 10.1002/pbc.26641

https://www.ncbi.nlm.nih.gov/pubmed/28544698 (打开新窗口)

A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. (打开新窗口)

Shpilberg O, Blumenthal R, Sofer O, Katz Y, Chetrit A, Ramot B, Eldor A, Ben-Bassat I.

来源‎: Leuk Lymphoma 1995;19(1-2):141-4.

检索‎: PubMed 8574160

DOI码‎: 10.3109/10428199509059668

https://www.ncbi.nlm.nih.gov/pubmed/8574160 (打开新窗口)

重组活化凝血因子VII(rFVIIa)

Pediatric off-label use of recombinant factor VIIa. (打开新窗口)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

来源‎: Pediatrics 2009;123(3):1066-72.

检索‎: PubMed 19255041

DOI码‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (打开新窗口)

Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience. (打开新窗口)

Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A.

来源‎: Indian J Pediatr 2011;78(8):961-8.

检索‎: PubMed 21328080

DOI码‎: 10.1007/s12098-011-0364-6

https://www.ncbi.nlm.nih.gov/pubmed/21328080 (打开新窗口)

Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label. (打开新窗口)

Croteau SE, Nakar C, Neufeld EJ, Shapiro A, Cooper DL

来源‎: Pediatr Blood Cancer 2016;63(10):1822-8.

检索‎: PubMed 27232114

DOI码‎: 10.1002/pbc.26082

https://www.ncbi.nlm.nih.gov/pubmed/27232114 (打开新窗口)

Use of recombinant factor VIIa prior to lumbar puncture in pediatric patients with acute leukemia. (打开新窗口)

Das P, Carcao M, Hitzler J

来源‎: Pediatr Blood Cancer 2006;47(2):206-9.

检索‎: PubMed 16007583

DOI码‎: 10.1002/pbc.20467

https://www.ncbi.nlm.nih.gov/pubmed/16007583 (打开新窗口)

A comprehensive review of rFVIIa use in a tertiary care pediatric center. (打开新窗口)

Heller M, Lau W, Pazmino-Canizares J, Brandão LR, Carcao M

来源‎: Pediatr Blood Cancer 2008;50(5):1013-7.

检索‎: PubMed 17960639

DOI码‎: 10.1002/pbc.21375

https://www.ncbi.nlm.nih.gov/pubmed/17960639 (打开新窗口)

Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia. (打开新窗口)

Kurekci AE, Atay AA, Okutan V, Yavuz ST, Ozcan O

来源‎: Blood Coagul Fibrinolysis 2005;16(2):145-7.

检索‎: PubMed 15741803

DOI码‎: 10.1097/01.mbc.0000161569.66764.70

https://www.ncbi.nlm.nih.gov/pubmed/15741803 (打开新窗口)

Off-label use of recombinant factor VIIa in pediatric patients. (打开新窗口)

McQuilten ZK, Barnes C, Zatta A, Phillips LE; Haemostasis Registry Steering Committee

来源‎: Pediatrics 2012;129(6):e1533-40.

检索‎: PubMed 22641758

DOI码‎: 10.1542/peds.2011-2561

https://www.ncbi.nlm.nih.gov/pubmed/22641758 (打开新窗口)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (打开新窗口)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

来源‎: Pediatr Hematol Oncol 2008;25(4):301-11.

检索‎: PubMed 18484474

DOI码‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (打开新窗口)

去氨加压素

The use of DDAVP in children with bleeding disorders. (打开新窗口)

Ben-Ami T, Revel-Vilk S

来源‎: Pediatr Blood Cancer 2013;60 Suppl 1:S41-3.

检索‎: PubMed 23109357

DOI码‎: 10.1002/pbc.24335

https://www.ncbi.nlm.nih.gov/pubmed/23109357 (打开新窗口)

局部止血药

The use of Tachosil as hemostatic sealant in nephron sparing surgery for Wilms tumor: preliminary observations. (打开新窗口)

Mele E, Ceccanti S, Schiavetti A, Bosco S, Masselli G, Cozzi DA

来源‎: J Pediatr Surg 2013;48(3):689-94.

检索‎: PubMed 23480936

DOI码‎: 10.1016/j.jpedsurg.2013.01.019

https://www.ncbi.nlm.nih.gov/pubmed/23480936 (打开新窗口)